Table 4.
Univariate Analysis of Clinical Factors Affecting the Eradication Rate in Each Group
| Clinical factor | Standard triple therapy plus probiotics | Concomitant therapy | ||||
|---|---|---|---|---|---|---|
|
|
|
|||||
| No. of patients | Eradication rate, % | p-value | No. of patients | Eradication rate, % | p-value | |
| Sex | 0.143 | 0.374 | ||||
| Male | 125 | 89.9 | 36 | 94.4 | ||
| Female | 149 | 84.0 | 35 | 88.6 | ||
| Presence of ulcer | 0.796 | 0.016 | ||||
| (+) | 193 | 87.6 | 56 | 96.4 | ||
| (−) | 81 | 86.4 | 15 | 73.3 | ||
| Atrophic change | 0.191 | 0.107 | ||||
| (+) | 144 | 84.7 | 35 | 85.7 | ||
| (−) | 130 | 90.0 | 36 | 97.2 | ||
| Intestinal metaplasia | 0.726 | 0.658 | ||||
| (+) | 110 | 86.4 | 22 | 95.5 | ||
| (−) | 164 | 87.8 | 49 | 89.8 | ||
| HTN | 0.212 | 0.625 | ||||
| (+) | 43 | 81.4 | 17 | 88.2 | ||
| (−) | 231 | 88.3 | 54 | 92.6 | ||
| Type 2 DM | 1.000 | 0.006 | ||||
| (+) | 17 | 88.2 | 6 | 50.0 | ||
| (−) | 257 | 87.2 | 65 | 95.4 | ||
| Alcohol intake | 0.366 | 0.166 | ||||
| (+) | 97 | 89.7 | 18 | 83.3 | ||
| (−) | 177 | 85.9 | 53 | 94.3 | ||
| Current smoking | 0.545 | 0.611 | ||||
| (+) | 66 | 89.4 | 16 | 87.5 | ||
| (−) | 208 | 86.5 | 55 | 92.7 | ||
| Probiotics | 0.048 | |||||
| STP-I | 72 | 80.6 | ||||
| STP-II | 202 | 89.6 | ||||
Patients who did not take more than 90% of the patients were included in the analysis because they were eradicated.
HTN, hypertension; DM, diabetes mellitus; STP, standard triple therapy plus probiotics; STP-I, Bacillus subtilis and Streptococcus faecium culture; STP-II, Lactobacillus casei var. rhamnosus culture.